About 1 in 8 women will be diagnosed with breast cancer during their lifetime and now, a new study has found that many breast cancer patients can skip chemo.
The report, which is being considered a landmark study, is the largest ever done of breast cancer treatment, and comes as the focus turns to cases where chemo’s value increasingly is in doubt. Dr. Lucio Miele of LSU Health New Orleans says chemo’s prevalence came from a risk mitigation mentally in the medical field.
"Once these cancers return," said Miele, "they are generally resistant to everything. Hormone therapy and chemotherapy."
There are some that are hesitant to put their full faith into the studies results after years of campaigns advocating for chemotherapy. Dr. Miele says it is time to trust the research.
Breast cancer is the second leading cause of cancer death among women.